Honz Pharmaceutical Co., Ltd., is a publicly listed company centered on medicines for children. It devotes to becoming the leading brand in the children’s healthcare industry in China.
Honz Pharma has five highly automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong, and is constructing a new manufacturing base meeting the EU GMP standards in Zhongshan, Guangdong.
Honz Pharma emphasizes the R&D and innovation of products, has dedicated advanced equipment and exceptional R&D staff, and has invested hundreds of millions of RMB in this field.
Honz Pharma has formed an integrated structure of products, created a successful line of children’s medicines centered on “Honz” branded products, and launched unique Honz star products such as “Ruizhiqing”, “Kangzhisong”, “Kangzhitai”,and “Jinlishuang”.
2011, Honz Pharma jointly founded the Honz Healthy Growth Foundation with the China Children and Teenagers Foundation, with the mission statement of taking care of the healthy growth of children.
Honz will carry on the cooperate legacy of “Sincere, Caring, Innovative”, and shoulder the responsibility of caring for and supporting children’s health and well-being.
Medicine for Adults
Pioglitazone Hydrochloride Orally Disintegrating Tablets
Jiapuxi
Exclusive hydrochloride orally disintegrating tablets Preferred medication for drug combination, elder people, patients with dysphagia
1. Unique dosage form：Exclusive orally disintegrating tablets are suitable for elder people, patients with dysphagia and reduce side effects for gastrointestinal tract and liver.
2. Unique pharmacological properties: New generation of insulin sensitizing agents can delay the development of diabetes, reduce cardiovascular complications.
3. Protection of renal function：Slow down the development of diabetic nephropathy .Patients with renal impairment don’t have to adjust dosage when taking the tablets.
4. Safety of medication is high: No serious liver toxicity of troglitazone and rosiglitazone on cardiovascular risk.
Ruipule
Wechat Account：honzpharma
Your position is：
